FOXO Technologies Inc.
FOXO Technologies Inc.
Your view on FOXO
Overview
What the company does, where it operates, and who runs it.
About FOXO Technologies Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Seamus Lagan
- Headquarters
- 729 North Washington Avenue, West Palm Beach, MN, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Seamus Lagan
- Headquarters
- 729 North Washington Avenue, West Palm Beach, MN, US
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry.
The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey.
It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance.
The company was founded in 2019 and is based in Minneapolis, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for FOXO Technologies Inc., and the rating behind it. FOXO last traded at $0.0003, 0.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for FOXO Technologies Inc.. Starting points for FOXO Technologies Inc.: P/E 0.0, EPS -$3.34, beta 2.72 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for FOXO Technologies Inc.. FOXO Technologies Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for FOXO Technologies Inc.. Trailing twelve-month EPS for FOXO Technologies Inc. stands at -$3.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for FOXO Technologies Inc.. FOXO Technologies Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
FOXO Technologies Inc. valued side by side against its closest peers. FOXO Technologies Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold FOXO Technologies Inc., and how their positions are changing. At a $8,997 market value, institutional positions materially move FOXO Technologies Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by FOXO Technologies Inc. executives and directors. Shares of FOXO Technologies Inc. have traded between $0.0002 and $14.86 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming FOXO Technologies Inc.. FOXO Technologies Inc. is a $8,997 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming FOXO Technologies Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for FOXO Technologies Inc.. Coverage tracks FOXO Technologies Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.